Search research articles
Contact Us
Filters
Showing results (241-250 of 254) with videos related to
Page
of 26
Sort By:
Elife
|
January 25, 2022
Preexisting memory CD4 T cells in naïve individuals confer robust immunity upon hepatitis B vaccination
George Elias, Pieter Meysman, Esther Bartholomeus, et al.
The Journal of Infectious Diseases
|
October 3, 2023
Diagnosing Viral Infections Through T-Cell Receptor Sequencing of Activated CD8+ T Cells
Alexandra Vujkovic, My Ha, Tessa de Block, et al.
Clinical Drug Investigation
|
July 22, 2021
Direct and Indirect Costs of Influenza-Like Illness Treated with and Without Oseltamivir in 15 European Countries: A Descriptive Analysis Alongside the Randomised Controlled ALIC<sup>4</sup>E Trial
Xiao Li, Joke Bilcke, Alike W van der Velden, et al.
Immunogenetics
|
December 3, 2017
Increased herpes zoster risk associated with poor HLA-A immediate early 62 protein (IE62) affinity
Pieter Meysman, Nicolas De Neuter, Esther Bartholomeus, et al.
Science Advances
|
May 16, 2025
Celluloepidemiology-A paradigm for quantifying infectious disease dynamics on a population level
My K Ha, Anna Postovskaya, Maria Kuznetsova, et al.
Lancet (London, England)
|
August 13, 2021
Towards a European strategy to address the COVID-19 pandemic
Viola Priesemann, Rudi Balling, Simon Bauer, et al.
Epidemics
|
April 21, 2024
Characterising information gains and losses when collecting multiple epidemic model outputs
Katharine Sherratt, Ajitesh Srivastava, Kylie Ainslie, et al.
Vaccine
|
September 5, 2017
Influenza epidemiology and immunization during pregnancy: Final report of a World Health Organization working group
Deshayne B Fell, Eduardo Azziz-Baumgartner, Michael G Baker, et al.
The Lancet Regional Health. Europe
|
August 4, 2021
A look into the future of the COVID-19 pandemic in Europe: an expert consultation
Emil Nafis Iftekhar, Viola Priesemann, Rudi Balling, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
September 21, 2022
Cost-effectiveness of adding oseltamivir to primary care for influenza-like-illness: economic evaluation alongside the randomised controlled ALIC<sup>4</sup>E trial in 15 European countries
Xiao Li, Joke Bilcke, Alike W van der Velden, et al.
Page
of 26
Search research articles
Search
Showing results (241-250 of 254) with videos related to
Sort By:
Page
of 26
Elife
|
January 25, 2022
Preexisting memory CD4 T cells in naïve individuals confer robust immunity upon hepatitis B vaccination
George Elias, Pieter Meysman, Esther Bartholomeus, et al.
The Journal of Infectious Diseases
|
October 3, 2023
Diagnosing Viral Infections Through T-Cell Receptor Sequencing of Activated CD8+ T Cells
Alexandra Vujkovic, My Ha, Tessa de Block, et al.
Clinical Drug Investigation
|
July 22, 2021
Direct and Indirect Costs of Influenza-Like Illness Treated with and Without Oseltamivir in 15 European Countries: A Descriptive Analysis Alongside the Randomised Controlled ALIC<sup>4</sup>E Trial
Xiao Li, Joke Bilcke, Alike W van der Velden, et al.
Immunogenetics
|
December 3, 2017
Increased herpes zoster risk associated with poor HLA-A immediate early 62 protein (IE62) affinity
Pieter Meysman, Nicolas De Neuter, Esther Bartholomeus, et al.
Science Advances
|
May 16, 2025
Celluloepidemiology-A paradigm for quantifying infectious disease dynamics on a population level
My K Ha, Anna Postovskaya, Maria Kuznetsova, et al.
Lancet (London, England)
|
August 13, 2021
Towards a European strategy to address the COVID-19 pandemic
Viola Priesemann, Rudi Balling, Simon Bauer, et al.
Epidemics
|
April 21, 2024
Characterising information gains and losses when collecting multiple epidemic model outputs
Katharine Sherratt, Ajitesh Srivastava, Kylie Ainslie, et al.
Vaccine
|
September 5, 2017
Influenza epidemiology and immunization during pregnancy: Final report of a World Health Organization working group
Deshayne B Fell, Eduardo Azziz-Baumgartner, Michael G Baker, et al.
The Lancet Regional Health. Europe
|
August 4, 2021
A look into the future of the COVID-19 pandemic in Europe: an expert consultation
Emil Nafis Iftekhar, Viola Priesemann, Rudi Balling, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
September 21, 2022
Cost-effectiveness of adding oseltamivir to primary care for influenza-like-illness: economic evaluation alongside the randomised controlled ALIC<sup>4</sup>E trial in 15 European countries
Xiao Li, Joke Bilcke, Alike W van der Velden, et al.
Page
of 26